National Cancer Center, Korea

This study is testing whether the drug lurbinectedin can help control advanced pancreatic neuroendocrine tumors in patients whose previous treatments have stopped working. The trial will enroll 46 participants with high-grade tumors to measure how well the drug shrinks tumors and…

This study is for women whose ovarian cancer has returned and stopped responding to standard platinum chemotherapy. It aims to see if a major surgery to remove visible tumors, followed by a heated chemotherapy solution washed directly inside the abdomen, helps patients live longe…

This study is testing whether a combination of two drugs, pembrolizumab (given by IV) and lenvatinib (taken as a pill), can help control advanced adrenal cancer that has continued to grow despite standard chemotherapy. It will involve about 30 adult patients who have already trie…

This study is creating a large national registry of pancreatic cancer patients to collect real-world information on how the disease is treated and how patients fare over time. It will analyze past medical records from 2010 onward and follow over 800 new patients through 2029. The…